An immunosuppressive/mitogenic (ISM) protein was purified from the supernatants of cultures of Streptococcus sobrinus with an isoelectric point of 4.75 and a relative molecular mass of 38 kDa (p38). Treatment of C57BL/6 mice with p38 induced an increase in the numbers of non-specific splenic Ig-secreting plaque-forming cells (PFC) with peak responses on day 3 for IgM-secreting PFC and on day 5 for IgG-secreting PFC, with an isotype pattern consisting predominantly of IgG2a and IgG2b. This increase was accompanied by a lymphocyte blastogenic response of both T and B lymphocytes. The in vitro effects of p38 on pure B, T and total splenic lymphocytes indicated that this ISM protein was primarily a B cell mitogen, being T cells activated subsequently by the generation of B blasts. Suppression of the murine primary immune response against sheep red blood cells was observed in C57BL/6 mice treated 4 days before with p38. The amino acid sequence of the N-terminus of p38 has a significant similarity with several enolases, particularly with rabbit enolase. However, the biological effects ascribed to p38 have not been detected after in vivo treatment with that enolase. The immunosuppressive effect of p38 was abrogated by depletion of IL-10 but not of IL-4. In agreement with this observation IL-10 was the only cytokine detected in serum of C57BL/6 mice after p38 treatment and the peak of serum levels was observed as soon as 2 h after treatment.
Introduction
Combined immunosuppression and polyclonal lymphocyte mitogenicity is a common feature in microbial infection (1) (2) (3) (4) (5) (6) (7) (8) (9) . Both immunosuppression and lymphocyte mitogenicity effects were ascribed to immunosuppressive/mitogenic (ISM) microbial proteins (1, 2, 4, 8, (10) (11) (12) . Among these ISM proteins we have particularly studied those proteins produced by Streptococcus intermedius (1) , Streptococcus mutans (4), African swine fever virus (ASFV) (2) and Candida albicans (8) . We have shown that these ISM proteins seem to play an important role in the pathogenicity and survival of the microorganism in the host because: (i) treatment of the host with ISM proteins facilitates microbial growth and diminishes host resistance (8, 13, 14) , (ii) selective loss of ISM protein production by microbial strains correlates with 'attenuation', loss of virulence Received 4 December 1996, accepted 11 August 1997 (8, 13, 14) , and (iii) specific immunization against ISM proteins increases host resistance (15) and often results in a complete protection (16) . On the basis of these observations it was postulated (17) that the adequate strategy of immunoprotection will be the immunization against the secreted ISM proteins rather than against the microbial constitutive epitopes. Streptococcus sobrinus is a particularly important bacterium since it is considered one of the principal agents of dental caries (18) (19) (20) (21) . Treatment of dental caries is probably the world's costliest due to its wide distribution (20, 22) and does not include a viable preventive approach based upon the control of bacterial factors involved in this pathology (22, 23) .
In the present report we decided to search for an ISM protein produced by S. sobrinus, and to define the biochemical and biological characteristics of such protein. Since host T h 1 and T h 2 responses were recently considered as neutralizing and favouring respectively microbial growth (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) , particular attention was paid to the involvement of T h 2 ILs in the analysis of the immunobiological effects of p38.
Methods

Mice
Male C57BL/6 mice, 8-10 weeks old, were bred at the Gulbenkian Institute (Oeiras, Portugal).
Bacteria
S. sobrinus strain 6715, able to induce dental caries in rats (34, 35 ) (a kind gift of Dr Klausen, Department of Oral Diagnosis and Microbiology, Royal Dental College, University of Copenhagen, Denmark), was stored at -70°C in ToddHewitt broth medium (Difco, Detroit, MI) with 10% (v/v) glycerol. The pathogenicity of the bacterium was maintained every 3 months by i.p. inoculations of S. sobrinus into C57BL/6 mice and subsequent recovery of the bacterium from the peritoneal exudates. An attenuated form of the same strain of S. sobrinus, unable to induce dental caries, was obtained after 60 passages in Todd-Hewitt agar medium.
Preparation of the crude extracellular products of S. sobrinus (CEP-Ss)
Pathogenic or attenuated S. sobrinus was cultured anaerobically in Todd-Hewitt broth medium for 3 days at 37°C at an initial concentration of 10 8 microorganisms/l of medium. The cultures were then centrifuged at 29,000 g for 30 min, and the supernatants were filtered through a 0.22 µm pore size filters (Millipore, Bedford, MA) and concentrated by vacuum dialysis through a Visking 100/8FT dialysis membrane with a 12,000 Da cut-off. This product was designated crude extracellular product of S. sobrinus, being CEP-Ss path or CEP-Ss inact when obtained from pathogenic or attenuated S. sobrinus cultures respectively.
Immunization and immunosuppression protocols
Immunization of C57BL/6 mice with sheep red blood cells (SRBC), as previously described exhaustively (1, 2, 4, 8) , was observed in mice treated 4 days before immunization with CEP-Ss path or inact, the fractions thereof, the purified protein and rabbit enolase (Sigma, St Louis, MO). Control mice were injected i.p. at the same time with PBS.
Plaque-forming cells (PFC) assays
Evaluations of the immune responses by the numbers of splenic IgM-secreting PFC and of non-specific Ig production by the Protein A assay were performed as described in detail elsewhere (1, 2, 4, 8) .
Fractionation of CEP-Ss path and inact
Ion-exchange chromatography of CEP-Ss path and inact was performed in DEAE-cellulose (DE52; Pharmacia, Piscataway, NJ), using a continuous molarity gradient of 0.05-1.0 M NaCl in 0.05M Tris-HCl, pH 7.0. The fractions were concentrated by vacuum dialysis. Protein concentration was determined by the method of Lowry et al. (36) .
Subfractionation of CEP-Ss path
The material eluted from ion-exchange chromatography with immunosuppressive activity was subfractionated by preparative isoelectric focusing (PIEF) in sucrose and a pH gradient of 2.5-10 using a mixture of ampholytes of pH 2.5-5.0 and 3.0-10.0 (Pharmacia) as previously described in detail (14) .
Purification of the immunosuppressive protein
The ISM protein was then purified from the biologically active material obtained after PIEF by preparative PAGE (37, 38) , performed in 5% polyacrylamide gels according to methodology also previously described in detail (8) .
Electrophoretic analysis of the purified biologically active protein
Analytical isoelectric focusing of the purified biologically active protein and of a mixture of proteins of known isoelectric point was performed with ampholytes of pH 3-9 in strips (Phastgel IEF 3-9; Pharmacia) by using computerized systems for the separation and staining (Phast system separation control and development units; Pharmacia). After a prerun of 10 min, 1 µl of each sample was applied and analytical isoelectric focusing was performed over 30 min. These gel strips were also stained with silver nitrate, methylene blue or periodic acid-Schiff. The relative molecular mass of this protein was determined by SDS (Sigma)-PAGE (39) . SDS-PAGE preparations were stained with silver nitrate.
N-terminal amino acid sequencing
The purified protein was separated by SDS-PAGE and transferred to an Imobilon P membrane in 10% methanol, 10 mM CAPS buffer. The N-terminal amino acid sequence of the protein was then analyzed on an Applied Biosystems model 479A gas-phase sequencer equipped with a 120 A PH analyser. The determined sequence was compared with those contained in updated versions of the Swiss Prot and NBRF/ PIR protein databanks using the FASTA program (40) .
Splenic lymphocyte purifications and in vitro assays
T and B cell-enriched splenic populations, cultures of total, B or T splenic lymphocytes and evaluation of the proliferative responses by incorporation of [ 3 H]thymidine were performed as previously described in detail (1, 13, 41, 42) . The degree of purification of T and B cells populations was evaluated by flow cytometry analysis. Lipopolysacharide (LPS) obtained from Brucella abortus equi (Difco) and p38 were used as stimulants at final concentrations of 12.5 µg/ml of LPS or of 6.25, 12.5 or 25 µg/ml of the ISM protein. Alternatively, some cultures of unfractionated and T splenic lymphocytes were carried out over 5 days. In this particular case a final concentration of 6.25 µg/ml of p38 was used as a single stimulant. Stimulation of the cultures was also evaluated by Protein A PFC and the flow cytometry analysis was determined as below.
Serum IL determination
The mouse serum cytokine titers of IFN-γ, IL-2, IL-4 and IL-10 were determined with the Intertest-10ϫ TM ELISA kit (Genzyme, Cambridge, MA).
IL depletion protocols
Depletion of IL-4 and IL-10 was accomplished by injecting C57BL/6 mice i.p. with 1 mg of rat IgG1 mAb against each IL 2 h before p38 treatment or 2 days before bacterial particle immunization. These mAb were obtained by growing hybridomas 11-B-11 (anti-IL-4) and JES5-2A5 (anti-IL-10) (kindly supplied by Dr Anne O'Garra, DNAX Institute, Palo Alto, CA) in the peritoneal cavity of C57BL/6 nu/nu mice. All mAb were purified from ascitic fluids by ammonium sulphate precipitation and by Protein A-affinity chromatography (43) . The amount of the mAb used has proven to be effective in the depletion of each IL (Dr Anne O'Garra, pers. commun.). One milligram of rat IgG1 (Zymed, San Francisco, CA) with unrelated specificity was used to treat control mice following the same protocol of the specific mAb.
Immunofluorescence and flow cytometry analysis
The spleen cells suspension was prepared by teasing the organ in cold BSS supplemented with 3% of FCS (Gibco Biocult, Glasgow, UK). The cell suspension was washed twice in the same buffer and then suspended in PBS supplemented with 3% of FCS and with 10 mM of sodium azide (Sigma). Dead cells were excluded by propidium iodide incorporation. Analysis of surface markers of the splenic cell populations was performed in a FACScan (Becton Dickinson, San Jose, CA) with the Lysys II software (Becton Dickinson). The following mAb were used for the surface markers: rat anti-mouse CD4-phycoerythrin conjugate (Coulter Immunology, Hialeah, FL), rat anti-mouse CD8-FITC conjugate (Coulter Immunology) and goat anti-mouse IgM-FITC conjugate (Southern Biotechnology Associates, Birmingham, AL).
Statistical analyses
Comparisons between p38-treated and p38-untreated mice were analysed by Student's t-test. Figure 1 shows the fractionation of CEP-Ss path by ionexchange chromatography with continuous increasing NaCl gradient from 0.05 to 1.0 M at neutral pH. Four fractions (F1-F4 DEAE) were obtained based on optical readings at 280 nm. This pattern was found to be reproducible in several preparations. The immunosuppressive effect on the primary immune response against SRBC of C57BL/6 mice evaluated by the numbers of splenic anti-SRBC IgM-secreting PFC of CEP-Ss was mainly detected in the F2 and F3 DEAE path ( Table 1) . None of the fractions obtained from the attenuated culture, F1-F4 DEAE inact, was suppressive when compared to the PBS-treated mice (Table 1 ). Figure 1 also shows that the subfractionation of a pool of several (F2 ϩ F3) DEAE path by PIEF resulted in five subfractions, FЈ1-FЈ5 PIEF, identified by optical density at 280 nm and by the pH values. This pattern was also found to be reproducible in several preparations. The biological activity was detected mainly in FЈ3 PIEF (Table  1) , with an isoelectric point between 4.45 and 4.87 (Fig. 1) . The immunosuppressive activity increased considerably per proteinaceous concentration over the purification procedure. Thus, although the immunosuppressive effect was distributed in two and one fractions after ion-exchange chromatography and PIEF respectively, the numbers of splenic IgM-secreting PFC of C57BL/6 mice treated with 200 µg of F2 or F3 DEAE were~25% of the control values, whereas the suppressive effect of 100 µg of FЈ3 PIEF equalled 7% of the control values (Table 1) . a Data are from 5 days after SRBC immunization of untreated C57BL/6 mice or mice treated 4 days before immunization with a single i.p. injection of the designated fraction or rabbit enolase.
Results
Fractionation of CEP-Ss path by DEAE-cellulose and semipurification by preparative isoelectric focusing
b The results are means Ϯ SD of four samples and are a representative experiment repeated three times. The significant values are given in italic (P Ͻ 0.05) or bold (P Ͻ 0.01 or P Ͻ 0.001).
c Percentage of values found in PBS-treated mice (control).
Purification and characterization of the immmunosuppressive protein
As shown in Fig. 2 , two silver stained bands were detected in FЈ3 PIEF after PAGE. These bands were not stainable by methylene blue or periodic acid-Schiff. The immunosuppressive activity was detected in the material electroeluted from the more-cathodal band (Table 1) . After electroelution this band clearly showed a more anodal behaviour (Fig. 2 ) without losing the immunosuppressive activity. The material contained in this band represented a pure protein because it was revealed as a single silver nitrate band in SDS-PAGE (Fig.  2) . Likewise, the immunosuppressive effect per microgram of protein increased from FЈ3 PIEF to the pure ISM; the numbers of IgM-secreting PFC of C57BL/6 mice treated with 100 µg of the former fraction or 50 µg of the pure ISM protein in both cases equalled 7% of the control values. Comparison with standard proteins of known relative masses indicates that the protein has a relative molecular mass of 38 kDa (Fig. 2) . Therefore, this protein was designated as p38. After analytical isoelectric focusing and comparison with proteins of known isoelectric point, it was seen that the isoelectric point of p38 equalled 4.75 (Fig. 2) .
Structural analysis of the N-terminal amino acid sequence of p38
The sequence of the first 18 N-terminal amino acids of the p38 is shown in Fig. 3 . Although the N-terminus of p38 is not represented in an updated version of protein databanks, comparison with other protein sequences revealed significant similarity with enolases from bacterium (Escherichia coli), yeast (Saccharomyces cerevisiae), mouse, rat, rabbit and humans (Fig. 3) . However, as opposed to p38, 50 µg of rabbit enolase was unable to suppress the murine primary response against SRBC (Table 1) .
In vivo proliferative and blastogenic response to p38
A considerable increase in the numbers of splenic nonspecific IgM-and IgG-secreting PFC was observed, in com-parison with controls, when C57BL/6 mice were treated with p38 (Fig. 4) . The increase in the numbers of non-specific IGsecreting PFC reached the highest value on day 3 for the IgM and on day 5 for the IgG isotypes after treatment with p38. The isotype restriction pattern, of the ratios between p38-treated and p38-untreated C57BL/6 mice taken on day 5 after treatment, was: IgG2a Ͼ IgG2b Ͼ IgG1 Ͼ IgG3 Ͼ IgM. As also depicted in Fig. 4 , the numbers of total and large B (IgM ϩ ) and CD4 ϩ lymphocytes increased in the spleen of C57BL/6 mice 5 days after treatment with p38. No significant differences were observed between p38-treated The results are means of quadruplicated samples. As the SD were never Ͼ20% and in 90% of the cases were Ͻ10% of the mean of the PFC assays, they were omitted for simplicity. In this and Fig. 6 , p38 treatment was performed by an i.p. injection of 50 µg of ISM protein.
(B) Number of splenic non-specific IgM-and IgG-secreting PFC and cell size distribution, assessed by forward light scatter, of IgM ϩ (I) and CD4 ϩ (II) lymphocytes in controls (Day 0) and 5 days after p38 treatment (Day 5). The absolute numbers were: (1) 65.6ϫ10 6 Ϯ 3.32ϫ10 6 and 90.4ϫ10 6 Ϯ 5.6ϫ10 6 for total numbers of IgM ϩ cells observed on day 0 and on day 5 respectively (significant difference, P Ͻ 0.01), (2) 10.0ϫ10 6 Ϯ 1.84ϫ10 6 and 27.1ϫ10 6 Ϯ 2.8ϫ10 6 for the numbers of large IgM ϩ cells observed on day 0 and on day 5 respectively (significant difference, P Ͻ 0.01), (3) 22.4ϫ10 6 Ϯ 0.57ϫ10 6 and 25.0ϫ10 6 Ϯ 1.27ϫ10 6 for total CD4 ϩ cells observed on day 0 and on day 5 respectively (significant difference, P Ͻ 0.05), and (4) 0.8ϫ10 6 Ϯ 0.2ϫ10 6 and 2.0ϫ10 6 Ϯ 0.2ϫ10 6 for the numbers of large CD4 ϩ cells observed on day 0 and on day 5 respectively (significant difference, P Ͻ 0.01). In this panel and in panel (B) of and control mice in the numbers of total and large CD8 ϩ cells (data not shown). Figure 5 shows that the in vitro mitogenic effects of p38 on pure B murine splenic lymphocytes evaluated at day 2 by proliferative responses and at day 3 by the generation of PFC were at the same level of LPS-stimulated B cells. In contrast, only a small proliferation was detected in cultures of almost pure T cells (contaminated with 2% of B lymphocytes) when stimulated with p38. Moreover, this proliferative effect seems to be due to the contaminating B cells since the amount of [ 3 H]thymidine uptake was proportional to that observed in p38-stimulated cultures of B lymphocytes. These results are in agreement with the flow cytometry observation of 3 day p38-stimulated cultures of unfractionated splenic cells. Although a large amount of B blasts was observed in these cultures, all T cells remained of small size (Fig. 5) . However, late T cell stimulation, subsequent to B cell activation, also occurs since large (activated) CD4 cells were observed, also by flow cytometry, in cultures of unfractionated splenic cells 5 days after stimulation by p38 (Fig. 5 ). Subsequent T cell activation by B blasts is also reinforced by the lack of proliferation observed in cultures of T splenic lymphocytes 5 days after p38 stimulation (data not shown) and by the observation that cultures of unfractionated splenic cells (~50% of T and B lymphocytes) incorporated nearly the same amount of [ 3 H]thymidine as pure B cells cultures when stimulated with high amounts of p38 (Fig. 5) .
Predominant in vitro B cell mitogenicity of p38
The immunosuppressive effect of p38 is dependent on IL-10 production
As depicted in Fig. 6 , a rapid increase in the serum levels of IL-10 was observed in C57BL/6 mice with peak responses as soon as 2 h after p38 treatment. The serum levels of this cytokine declined progressively, reaching the undetectable control levels 24 h after the ISM protein treatment (Fig. 6 ).
In contrast, the serum levels of IL-2, IL-4 and IFN-γ were undetectable after p38 treatment, such as in the case of controls (data not shown). Figure 6 also shows that the immunosuppressive effect induced by p38 was abrogated in mice depleted of IL-10 but not of IL-4. No significant differences in the immune response to SRBC were observed in p38-untreated mice either depleted or not depleted of IL-10 or IL-4 ( Fig. 6 ). IL-10 depletion did not induce any alteration in B lymphocyte polyclonal activation induced by p38 (Fig. 6 ).
Discussion
Herewith, we report that S. sobrinus produces p38, an ISM protein such as S. intermedius, C. albicans and ASFV (1, 2, 8) . This heterogeneous group of microorganisms produces ISM proteins which are in biochemical and immunobiological terms relatively similar. The relative molecular masses of p38 and of the ISM proteins produced by ASFV (2) and by C. albicans (8) of 36 and 43 kDa respectively are rather close. Only the ISM protein produced by S. intermedius was reported to have a relative molecular mass of 90 kDa (p90) (44) and it cannot be excluded that this ISM protein is dimerized. Some degree of polymerization or adherence to irrelevant molecules cannot be excluded either with p38 since the purified protein is more anodal after two than after one PAGE. Similar protein complex dissociation after electrophoresis was also ascribed to p90 (44) . Also, all the reported ISM proteins have a low isoelectric point which is 4.25 for the ISM proteins produced by S. intermedius and C. albicans (8, 44) , 3.89 for the ISM protein produced by ASFV (2), and 4.75 for the now reported p38. Moreover, B cell polyclonal activation induced an isotype restriction pattern privileging IgG2a and IgG2b production, either after treatment with p38 or with the other ISM proteins described previously. However, similarity between the N-terminal sequence of p38 and the other ISM proteins has not been observed (16) . Thus, the molecular structure responsible for the mitogenic effect on B cells of each ISM protein needs further clarification. The N-terminal sequence of p38 is quite similar to the N-terminus of various enolases, suggesting that they may belong to the same protein family. However, the immunobiological properties of this ISM protein are not due to mere enolase activity because no immunosuppressive activity was observed in mice treated with the rabbit enolase, which is one of those with a partially similar N-terminal sequence to p38. An important increase in the survival of C. albicans (8) and of S. intermedius (13) was observed in mice when previously treated with the produced ISM protein, p43 and p90 respectively. These observations are probably due to the immunosuppressive effect of the ISM proteins which is quantitatively associated with lymphocyte polyclonal activation (2, 4, 8) . An interplay between production of IL-10 and IL-4 or IL-10 alone, T h 2 cell immune response and progression of infectious diseases has been reported (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) 45) . As postulated before, (17, 46) T h 2 responses, production of IL-10, subsequent immunosuppression and progression of infectious diseases may be elicited by B blasts induced by the ISM protein. The present report is in agreement with these assumptions.
The in vitro studies on T and B cell cultures stimulated by p38 indicate that this ISM protein is a direct B cell mitogen and does not display detectable direct stimulatory effects on T cells. However, as it was postulated before for other ISM proteins (17) , T lymphocytes are subsequently stimulated by B blasts. Moreover, the suppressive effect of p38 was abrogated in IL-10-depleted mice. Furthermore, IL-10 was the single cytokine detected in serum of C57BL/6 mice after p38 treatment. The observation that increased levels of IL-10 in serum occurred very shortly after p38 treatment are in agreement with the need for depletion of this cytokine before or soon after infection in order to prevent microbial growth (29, 33, 46, 47) . As opposed to some reports indicating that IL-4 is also crucial for microbial invasion, p38 effects do not seem to be dependent on this cytokine. No increased serum levels of IL-4 were observed after treatment with the ISM protein and the immunosuppressive effect of p38 was not abrogated by IL-4 depletion.
In the near future we aim to identify the amino acid structure of p38 as well as of the other described microbial ISM proteins. We believe that the knowledge of these structures together with the investigation of other possibilities of preventing IL-10 release will provide us with the tools needed for an efficient immunointervention and immunoprotection. 
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